Axa S.A. Has $6.13 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

AXA S.A. lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 60.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,693 shares of the medical device company's stock after selling 100,801 shares during the quarter. AXA S.A.'s holdings in Cooper Companies were worth $6,131,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Cooper Companies by 2.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after acquiring an additional 155,233 shares in the last quarter. JPMorgan Chase & Co. increased its position in Cooper Companies by 1.5% in the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock worth $460,066,000 after buying an additional 74,501 shares during the period. Geode Capital Management LLC increased its stake in shares of Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after purchasing an additional 109,907 shares during the period. Victory Capital Management Inc. boosted its position in Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after purchasing an additional 2,957,421 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Up 2.5%

Shares of COO stock traded up $2.09 during trading hours on Monday, hitting $84.36. 273,411 shares of the company were exchanged, compared to its average volume of 1,842,560. The business has a 50 day moving average of $80.54 and a two-hundred day moving average of $90.81. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The company has a market capitalization of $16.87 billion, a PE ratio of 43.26, a PEG ratio of 2.25 and a beta of 1.08. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have commented on COO. Piper Sandler restated an "overweight" rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup dropped their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Stifel Nicolaus decreased their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.